| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 04/03/2002 | EP0918507B1 Aerosol formulations |
| 04/03/2002 | CN1343120A Essential fatty acids in prevention of cardiovascular events |
| 04/03/2002 | CN1343112A Dual component dentinal desensitizing dentifrice |
| 04/03/2002 | CN1081913C Hair styling compositions containing silicone grafted polymer and low level of volatile hydrocarbon solvent |
| 04/02/2002 | US6365631 Method of treating sleep apnoea |
| 04/02/2002 | US6365630 Compositions and methods for inhibiting photoaging of skin |
| 04/02/2002 | US6365628 Fatty analogues for the treatment of diabetes |
| 04/02/2002 | CA2264117C Cold cream cosmetic composition |
| 04/02/2002 | CA2194798C Cosmetic compositions for the skin and/or hair photoprotection which are based on a sinergic mixture of filters, and uses thereof |
| 03/28/2002 | WO2002024909A2 Receptor nucleic acids and polypeptides |
| 03/28/2002 | WO2002024754A1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 03/28/2002 | WO2002024702A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/28/2002 | WO2002024690A2 Efficient process for the preparation of a factor xa inhibitor |
| 03/28/2002 | WO2002024145A2 Antiviral substances from plant cuticular and epicuticular material |
| 03/28/2002 | US20020037854 Use of at least one no synthase inhibitor for treating sensitive skin |
| 03/28/2002 | US20020037332 Licorice extract for use as a medicament |
| 03/28/2002 | US20020037324 Aqueous solubility pharmaceutical formulations |
| 03/28/2002 | DE10139115A1 Citalopram enthaltende pharmazeutische Zusammensetzung Citalopram pharmaceutical composition containing |
| 03/28/2002 | DE10045856A1 Colorant for keratin fibers, useful for coloring fur, wool, feathers and especially human hair, contains benzo(b)furan-3-one or benzo(b)thiophen-3-one derivative(s) and reactive carbonyl or methine-active compound(s) |
| 03/28/2002 | CA2424576A1 Efficient process for the preparation of a factor xa inhibitor |
| 03/28/2002 | CA2423071A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/27/2002 | EP1190717A2 Licorice extract for use as a medicament |
| 03/27/2002 | CN1342161A Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 03/27/2002 | CN1342091A Combinations of cardiovascular indications |
| 03/27/2002 | CN1342090A Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular disease |
| 03/26/2002 | US6362230 Alzheimer's disease |
| 03/26/2002 | US6362179 Psychological disorders; nervous system disorders |
| 03/26/2002 | US6362161 Copolymer-1 improvements on compositions of copolymers |
| 03/26/2002 | US6361769 Stimulation of host defense mechanisms against viral challenges |
| 03/21/2002 | WO2002022168A2 Vaccine against streptococcus pneumoniae |
| 03/21/2002 | WO2002022167A2 Vaccine against streptococcus penumoniae |
| 03/21/2002 | WO2002022164A1 Composition comprising immunogenic microparticles |
| 03/21/2002 | WO2002022143A1 A pharmaceutical composition for treating headache disease and process and uses thereof |
| 03/21/2002 | WO2002022110A2 Contraception process and administration form for the same |
| 03/21/2002 | WO2002022092A1 Hair dyeing agents containing indigo derivatives |
| 03/21/2002 | US20020035459 Pharmacokinetic-based drug design tool and method |
| 03/21/2002 | US20020035135 Oral administering; storage stability |
| 03/21/2002 | US20020035032 Providing finely divided nanocrystalline particles selected from metal oxides and metal hydroxides; contacting particles with a target substance selected from bacteria, fungi, viruses, toxins for sorbing target substane |
| 03/21/2002 | CA2422575A1 Composition comprising immunogenic microparticles |
| 03/21/2002 | CA2422002A1 Vaccine |
| 03/21/2002 | CA2421998A1 Vaccine against streptococcus pneumoniae |
| 03/21/2002 | CA2417716A1 Mri method involving the use of a hyperpolarized contrast agent |
| 03/20/2002 | EP1187834A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists |
| 03/20/2002 | EP1187629A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 03/20/2002 | EP1019050B1 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 03/20/2002 | EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/20/2002 | EP0837860B1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO(3,4-c]-1,2,4-TRIAZOLO(4,3-ALPHA]PYRIDINES |
| 03/20/2002 | EP0642351B1 New pharmaceutical uses of krill enzymes |
| 03/20/2002 | CN1341099A 2-aminopyridines containing fused ring substituents |
| 03/20/2002 | CN1341098A W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 03/20/2002 | CN1341019A Antitumour synergistic composition |
| 03/20/2002 | CN1341011A Oxidation dyeing method using N-acetylcysteine as reducing agent and laccase as oxidating agent |
| 03/19/2002 | US6359154 Exceptional utility as antitumor agents; bioavailability and nontoxic; oral administration; e.g., 10-hydroxy-10-deacetyl baccatin iii; anticarcinogenic agents |
| 03/19/2002 | US6358958 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/19/2002 | US6358937 Administering phosphatidic acid and lipid to treat drug abuse, addiction, or withdrawal and/or alcoholism |
| 03/19/2002 | US6358744 Stabilized human papillomavirus formulations |
| 03/19/2002 | US6358286 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
| 03/19/2002 | CA2206048C Topical skin care compositions containing thickened polyol carboxylic acid esters as skin conditioning agents |
| 03/19/2002 | CA2106975C Process for conditioning of water-soluble substances |
| 03/14/2002 | WO2002020038A2 Method for down-regulating ige |
| 03/14/2002 | WO2001082869A3 Anionic vinyl/dicarboxylic acid polymers and uses thereof |
| 03/14/2002 | WO2001082866A3 Cosmetic compositions containing film forming polymers plasticized with esters of malic acid |
| 03/14/2002 | WO2001066093A3 Sustained release ranolazine formulations |
| 03/14/2002 | WO2001064163A3 An improved herbal composition having antiallergic properties and a process for the preparation thereof |
| 03/14/2002 | WO2001055130A3 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 03/14/2002 | US20020032213 Macrolides |
| 03/14/2002 | US20020032211 Novel dihydronaphthalene compounds and processes of producing the same |
| 03/14/2002 | US20020032205 An alkyl amine substituted isobenzofuran compound useful for certain psychiatric and neurological disorders; potently binding to the 5-HT1A receptor |
| 03/14/2002 | US20020032173 Blood flow improvers and thrombosis preventives or remedies |
| 03/14/2002 | US20020032169 Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue |
| 03/14/2002 | US20020031530 In ovo vaccination against coccidiosis |
| 03/14/2002 | US20020031511 Chemically-modified group B polysaccharides of Neisseria meningitidis for use as vaccines |
| 03/14/2002 | US20020029429 Hair coloring compositions |
| 03/14/2002 | CA2421274A1 Method for down-regulating ige |
| 03/13/2002 | EP1186602A2 Omeprazole sodium salt and its use as anti-ulcer agent |
| 03/13/2002 | EP1185948A1 Method for screening and producing compound libraries |
| 03/13/2002 | EP1185274A1 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4 |
| 03/13/2002 | EP1185237A1 Synergistic antibacterial combination |
| 03/13/2002 | EP1132090A4 Method for producing an agent for treating non-cancerous pathologies of the organism |
| 03/13/2002 | EP0912155B1 Use of novel glass compositions in preparing dental glass pillars and support pillars, and method for producing the glass pillars |
| 03/13/2002 | EP0802910B1 Estrogen agonists/antagonists |
| 03/13/2002 | EP0717638B1 Cyclodextrins for the reduction of extravasation toxicity caused by cytotoxic compounds |
| 03/13/2002 | CN1340051A Heteroaryl-substituted quinoline-2-one derivatives useful asticancer agents |
| 03/13/2002 | CN1340043A Phenylalaninol derivatives |
| 03/13/2002 | CN1339967A Composition for treatinb obesity and aesthetic treating method |
| 03/13/2002 | CN1339944A Organoprotective solutions |
| 03/13/2002 | CN1339297A New medicine release system-liposolubility medicinal preparation |
| 03/12/2002 | US6355689 Antiinflammatory agents |
| 03/12/2002 | US6355684 Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 03/12/2002 | US6355280 For inhibiting cellular aging and for protection of the skin against negative environmental factors and pollutants |
| 03/12/2002 | CA2086438C Anti-herpes virus and cytomegalovirus oligomers |
| 03/12/2002 | CA2064077C T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 03/07/2002 | WO2002018369A2 Peptidomimetic protease inhibitors |
| 03/07/2002 | WO2002018346A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | WO2002018333A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 03/07/2002 | WO2001089457A3 Thrombopoietin mimetics |
| 03/07/2002 | WO2001087232A3 Allantoin-containing skin cream |
| 03/07/2002 | WO2001055178A3 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 03/07/2002 | US20020028920 Processes for preparing clarithromycin polymorphs |
| 03/07/2002 | US20020028819 Piperazinedione compounds |